Not all NTRK fusions in mesenchymal neoplasia are driver events: implications on classification and targeted therapy
Mohamed A Yakoub, Purvil Sukhadia, Carla Saoud, Meera Hameed, Cristina R Antonescu · 2026
Read Not all NTRK fusions in mesenchymal neoplasia are driver events: implications on classification and targeted therapy by Mohamed A Yakoub, Purvil Sukhadia, Carla Saoud, Meera Hameed, Cristina R Antonescu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13430059.txt.
Description
Mohamed Yakoub and colleagues warn that not every NTRK gene fusion drives a sarcoma. Their study from twenty twenty-six reviews a large tumour cohort. These fusions define one tumour family and guide targeted drugs. Finding one in another sarcoma type creates classification confusion.
Fusions were classed as true drivers or uncertain passengers. True drivers keep an intact, in-frame kinase section. Uncertain ones break the frame or lack that section. Forty-eight fusion cases were found across many sarcoma types. Pathologist-led and clinician-led testing found different case mixes. Treating passenger fusions as drivers could misdirect therapy. Careful fusion grading belongs in tumour board decisions.
Catalog record
| CREATOR | Mohamed A Yakoub, Purvil Sukhadia, Carla Saoud, Meera Hameed, Cristina R Antonescu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |